BRIEF-Titan Pharma receives FDA communication on ropinirole implant INDA
* Titan Pharmaceuticals receives FDA communication on ropinirole implant investigational new drug application
(Repeats to alerts)
OSLO, July 25 Norwegian oil and gas group Statoil reported second quarter operating results a touch below expectations on Thursday and maintained its guidance, including for both production and exploration activity.
State-controlled Statoil said adjusted operating profit fell 17 percent to 38 billion Norwegian crowns ($6.43 billion), trailing analysts' expectation for 40.7 billion crowns.
Its total equity production averaged 1.967 million barrels of oil equivalents per day in the quarter, more than expectations for 1.92 million barrels. ($1 = 5.9105 Norwegian crowns) (Reporting by Balazs Koranyi and Victoria Klesty)
* TSX closes down 69.96 points, or 0.45 percent, at 15,463.51
Feb 27 Travel website operator Priceline Group Inc reported a 17.4 percent rise in fourth-quarter revenue, driven by higher hotel bookings.